Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 2 Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Ovarian Epithelial 1

Interventions

Bevacizumab 75 Fluorouracil 55 Cetuximab 47 Oxaliplatin 43 Leucovorin 43 pembrolizumab 35 Irinotecan 33 Folfox protocol 24 Capecitabine 24 HMPL-013 22 Specimen Handling 18 trifluridine tipiracil drug combination 16 Nivolumab 15 Blood Specimen Collection 15 Panitumumab 14 regorafenib 13 Magnetic Resonance Spectroscopy 13 Trifluridine 12 Gemcitabine 12 Biopsy 12 Standard of Care 11 Cisplatin 11 sintilimab 10 Interviews as Topic 10 IFL protocol 10 Drug Therapy 10 Carboplatin 9 tislelizumab 8 Trastuzumab 8 Cyclophosphamide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Colorectal Neoplasms × Etodolac × Clear all

NCT03919461 2019-04-18

COMPIT-2

Assaf-Harofeh Medical Center

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡